This post was originally published on this site
Its medical technology segment makes medical devices, including orthopedic braces, reconstructive implants, and other products used for rehabilitation, physical therapy, and pain management.
The company is benefiting from its focus on product innovation, a healthy business system, and its cost-cutting initiatives. This led to a strong quarter, where CFX outpaced both its earnings and sales estimates. CFA has a current ratio of 1.6, which indicates it has more than enough liquidity to handle short-term debt.
